ArticlePLOS mental health2025
Contribution of narrative therapy in reduction of anxiety, depression and PTSD among survivors of the genocide against the Tutsi in 1994 in Rwanda.
Article in PLOS mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Identity Reconstruction as a Coping Mechanism in Addiction Recovery: A Pilot Stratified Randomized Controlled Trial of Narrative Therapy Group Intervention.European journal of investigation in health, psychology and education · 2026Article
- Integrating narrative medicine into post-genocide Rwandan healthcare: a call for trauma-responsive medical education.Frontiers in medicine · 2026Review
- Psychedelics and collective trauma: multisystemic resilience and recovery pathways among Nova festival survivors - a qualitative study.European journal of psychotraumatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 1994 genocide against the Tutsi in Rwanda caused profound psychological trauma among survivors, with long-lasting effects such as anxiety, depression, and post-traumatic stress disorder (PTSD). Narrative therapy, known for its ability to help individuals reconstruct their personal stories, is emerging as a promising intervention, though its effectiveness within Rwandan context has not been fully explored. This study therefore, aimed to assess the impact of narrative therapy on reducing symptoms of anxiety, depression, and PTSD in genocide survivors. It focused on how narrative therapy helps survivors reconstruct their narratives, enhance resilience, and foster emotional well-being. Eleven qualitative interviews were conducted with survivors of the 1994 Genocide against the Tutsi in Rwanda who participated in narrative therapy. Through purposive sampling, participants were selected for in-depth, semi-structured interviews. The interviews were transcribed and analyzed using thematic analysis to identify key themes and patterns. Thematic analysis revealed several key themes: survivors reported positive transformation in their narratives, which helped them reframe traumatic experiences and develop resilience. Participants strongly testified reduction in symptoms of anxiety, depression, and PTSD after engaging in narrative therapy. The communal aspects of therapy, such as group support, were also instrumental in fostering emotional recovery and a renewed sense of belonging. Narrative therapy appears to provide an effective framework for addressing psychological distress in genocide survivors by offering a structured process for narrative reconstruction and community healing. Further research is needed to confirm these findings and explore long-term outcomes. Culturally relevant mental health interventions, supported by sustainable funding, are essential to improving survivors' well-being and fostering resilience.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.